Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 2485–2520
- Headlines
- 3260
- Sources here
- 11
- Companies here
- 25
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Atricure (ATRC) Receives a Buy from Stifel Nicolaus
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Atricure (ATRC) with a $50.00 price target. This rating comes despite negative corporate insider sentiment and follows Atricure's latest earnings report showing increased revenue year-over-year. Another analyst from Piper Sandler also issued a Buy …
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST
West Pharmaceutical Services, Inc. (MIL:1WST) reported a total revenue of 2.62 billion EUR last year. The majority of this revenue, 2.12 billion EUR, came from its Proprietary Products segment, although this was a decrease from the previous year's 2.26 billion EUR. The United States …
NXGL|Nexgel Inc|Price:0.439|Chg%:+0.009
Nexgel Inc (NXGL) is trading at $0.439, up 2.09%, with a market capitalization of $3.57 million. The company, which specializes in hydrogel products for healthcare and consumer applications, has strong fundamentals, high growth potential, and institutional buying activity, although its stock performance has been …
ATRC|AtriCure Inc|Price:44.300|Chg%:+0.810
This article provides a detailed company profile of AtriCure Inc (ATRC), a medical technology company specializing in treatments for atrial fibrillation, LAA management, and post-operative pain. It outlines the company's business scope, financial data including its market cap and revenue sources, and lists key …
Microbot Medical Inc. Revenue Breakdown – NASDAQ:MBOT
This article provides a detailed financial overview of Microbot Medical Inc. (NASDAQ: MBOT), focusing on its revenue breakdown. It highlights the company's financial data, including statements, statistics, dividends, earnings, segments, and performance by source and country, all accessible through TradingView.
PDEX|Pro-Dex Inc|Price:54.930|Chg%:+0.260
Pro-Dex Inc. (PDEX) is trading at $54.930, up 0.48%, with a market capitalization of $175.38 million. The company, which specializes in surgical drivers and air motors, shows strong fundamentals including consistent revenue growth and high profit growth, despite recent institutional selling. Analysts currently rate …
ETFs Investing in Avantor, Inc. Stocks
This article provides a list of Exchange Traded Funds (ETFs) that hold Avantor, Inc. (A2PJN6) stocks, sorted by market value. It details various passive and active ETFs from issuers like BlackRock, Vanguard, and State Street Corp., noting their management style, expense ratio, AUM, price, …
DXR|Daxor Corp|Price:10.450|Chg%:+0.340
Daxor Corp (DXR) is currently trading at $10.45, up 3.27% on the day, with a market capitalization of $61.01M. Analysts have a "Buy" rating for DXR with a target price of $22.50, representing a significant upside. The company specializes in blood volume measurement technology, …
HBIO|Harvard Bioscience Inc|Price:6.000|Chg%:-0.190
Harvard Bioscience Inc. (HBIO) closed at $6.00, down 3.07% on July 24th. The company, which specializes in life science technologies, is considered fairly valued with strong fundamentals and high growth potential. Analysts rate HBIO as a "Buy" with a target price of $6.00, and …
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV
KBC Group NV reduced its stake in West Pharmaceutical Services (NYSE:WST) by 55.1% in the first quarter, selling over 11,000 shares. This comes as West Pharmaceutical Services reported a strong second quarter, exceeding revenue and EPS estimates, and raising its full-year guidance. Analysts maintain …
Is Intuitive’s AI-Driven Strategy and ESOP Shelf Registration Altering The Investment Case For Intuitive Surgical (ISRG)?
Intuitive Surgical recently filed a US$1.77 billion shelf registration for ESOP-linked shares and reported strong Q2 2026 revenues and net income. Concurrently, the company unveiled a five-layer AI framework and live telesurgical collaboration, indicating a move to integrate AI across its robotic ecosystem. These …
Dimensional Fund Advisors LP Acquires 203,672 Shares of AptarGroup, Inc. $ATR
Dimensional Fund Advisors LP significantly increased its stake in AptarGroup, Inc. by purchasing an additional 203,672 shares, bringing its total holding to over 1.5 million shares valued at approximately $189.6 million. This increase occurred in the first quarter, following AptarGroup's strong quarterly earnings report …
Bank of New York Mellon Corp Reduces Holdings in Baxter International Inc. $BAX
Bank of New York Mellon Corp decreased its stake in Baxter International Inc. by 13.1% in the first quarter, selling 396,247 shares and now owning 2,623,255 shares worth $44.07 million. Other institutional investors had mixed activity, with some increasing their holdings significantly. Analysts have …
Azenta, Inc. Revenue Breakdown – NASDAQ:AZTA
Azenta, Inc. (NASDAQ: AZTA) generated $593.82 million in revenue last year. The Sample Management Solutions segment was the top performer, contributing $324.59 million. The United States was the greatest regional contributor, accounting for $365.00 million.
Utah Medical Products (UTMD) Stock Margins Slip To 29% Net Profit Challenging Bullish Narratives
Utah Medical Products (UTMD) reported Q2 2026 revenues of $8.5 million and EPS of $0.84, with a trailing 12-month net profit margin of 29%, down from 32.3% previously. The company faces a 5.8% average annual earnings decline over five years, which challenges bullish narratives …
Intuitive Surgical, Inc. Revenue Breakdown – TURQUOISE:ISRGN
Intuitive Surgical, Inc. (ISRGN) reported total revenue of $10.06 billion, with its Instruments and Accessories segment contributing the most at $6.02 billion. The United States was the largest regional contributor, accounting for $6.82 billion of the company's revenue. These figures highlight the company's key …
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant
AngioDynamics (NASDAQ: ANGO) CEO James C. Clemmer settled a performance share grant from 2023, receiving 52,358 shares of Common Stock. The original grant of 184,361 units was based on multi-year performance metrics, with the remaining units forfeited. To cover tax withholding obligations, 26,728 shares …
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld
AngioDynamics Inc. CFO Stephen A. Trowbridge received 16,296 shares of common stock from the vesting of performance share units, which were part of a target grant of 57,381 units on July 19, 2023. The shares vested based on performance metrics and relative total shareholder …
Innovative Eyewear, Inc. Revenue Breakdown – NASDAQ:LUCY
Innovative Eyewear, Inc. (NASDAQ: LUCY) generated $2.66 million USD in revenue last year, with its e-commerce segment contributing the most at $2.43 million USD. All of the company's revenue originated from the United States, which saw a slight increase from $1.64 million USD the …
Intuitive Surgical, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Intuitive Surgical, Inc. recently reported earnings that surpassed analyst expectations, driven by higher revenue and earnings per share. Following these strong results, analysts have revised their price targets and earnings estimates upwards, indicating a positive outlook for the company's future performance. The general sentiment …
LeMaitre Vascular, Inc. Revenue Breakdown – NASDAQ:LMAT
LeMaitre Vascular, Inc. (FWB:LHU) generated 212.52 million EUR last year, primarily from its Medical Devices and Human Tissue Cryopreservation segment. The United States was the company's largest regional contributor, accounting for 120.53 million EUR of the revenue. This data highlights the key revenue drivers …
Did You Lose Money on Embecta Corp. (EMBC)? Levi & Korsinsky Urges Investors to Act Before August 17, 2026
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ:EMBC) on behalf of investors who suffered losses due to alleged securities fraud between November 25, 2025, and May 4, 2026. The lawsuit claims Embecta made misleading statements regarding its …
ICU Medical, Inc. Revenue Breakdown – TRADEGATE:IC7
ICU Medical, Inc. (TRADEGATE:IC7) generated 1.88 billion EUR in revenue last year, with its Consumables segment being the top performer, contributing 944.33 million EUR. The United States was the largest geographical contributor, accounting for 1.15 billion EUR of the company's revenue. The article provides …
West Pharmaceutical Services (WST) Stock Sees Margin Improvement Narrative Backed By Q2 2026 Results
West Pharmaceutical Services (WST) reported a strong Q2 2026 with increased revenue and basic EPS, demonstrating improved profitability with a trailing twelve-month net profit margin of 17%. The company's margin strength is attributed to higher-margin High Value Product components and GLP-1 related products, which …
Repligen Corp|Price:131.970|Chg%:-5.630
This article provides a company profile for Repligen Corporation (RGEN), a global life sciences company specializing in bioprocessing technologies. It details the company's focus areas, product portfolio, and key financial information. The article also lists company executives, their shareholdings, and institutional ownership data for …
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis
Sanara Medtech Inc (SMTI) currently holds a financial score of 7.31, ranking 117 out of 155 in the pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million, and its net …
Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for Repligen Corp (RGEN) by business segment and by region. For FY2025, filtration products were the largest segment, contributing 54.58% of revenue, while North America was the largest regional market at 49.00%. The data highlights the company's …
AtriCure (ATRC) Stock Faces Mixed Views As EPS Turnaround Tests Margin Narratives
AtriCure (ATRC) reported strong Q2 2026 results with a significant EPS turnaround and increased revenue, driven by improved margins and operating leverage rather than just revenue growth. While the profitability improvement supports bullish sentiment, the widely divergent valuation metrics (low DCF fair value vs. …
Icu Medical (ICUI) Q1 2024 Earnings Report - Results, Call & Slides
ICU Medical (ICUI) reported its Q1 2024 earnings, beating analyst expectations with an actual EPS of $0.96 against a consensus of $0.82 and revenue of $565.96 million compared to an expected $552.25 million. Despite beating estimates, the company's EPS saw a year-over-year decrease from …